TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/06/2026
Back to search
Official data from USPTO
LEGEND BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LEGEND BIOTECH
ST13
US500000098880290Class
5, 42
Filing
98880290
Registration
7890671
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
07/09/2026
Trademark type
Word
Nice classes
5, 42
Filing date
12/02/2024
Registration date
08/12/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2018-12-00
First use in commerce
2018-12-00
Drawing code
4
Owner type
03
Owner location
Bridgewater, NJ, US
Examiner
MCMORROW, RONALD G
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
LEGEND BIOTECH USA INC.
LEGEND BIOTECH USA INC.
Representatives
Preetha Chakrabarti Crowell & Moring LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and medical preparations for autoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposesautoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposesautoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; chemical preparations for pharmaceutical purposesautoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; drugs for medical purposesautoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; immunostimulants; medicines for human purposesautoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; pharmaceutical preparationsautoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; Pharmaceutical compositions for autoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; pharmaceuticals for autoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseasesnon-communicable diseasescancer or tumorinfectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical useLiving cells for medical use; vaccine preparation; Medical diagnostic preparations
Class 42
Scientific and technological servicesscientific researchanalysistesting in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposesfor others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposesfor others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming
Publications
History of USPTO decisions and trademark events.
14 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/06/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/06/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/24/2025
PUBO
PUBLISHED FOR OPPOSITION
06/24/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/18/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2025
DOCK
ASSIGNED TO EXAMINER
05/21/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2024
NWAP
NEW APPLICATION ENTERED
12/02/2024
Continuous trademark protection
Get notified about every new filing that threatens LEGEND BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.